The Genetic Wildcards
Lp(a) and familial hypercholesterolemia — risk that lifestyle alone can't fully address
Most of what's covered so far in this guide responds meaningfully to lifestyle change. This section covers two exceptions — genetic conditions that carry real cardiovascular risk largely independent of diet and exercise, and that matter precisely because they're so commonly missed.
Lipoprotein(a): The Test Almost Nobody Gets
About one in five people carry a genetic risk factor for heart disease that a standard cholesterol panel won't catch: Lipoprotein(a), or Lp(a) — a distinct lipoprotein particle whose blood level is roughly 80–90% genetically determined and barely responsive to diet, exercise, or standard cholesterol-lowering medication. A comprehensive clinical review describes it as an independent, causal risk factor for cardiovascular disease and aortic stenosis, with elevated levels carrying meaningfully higher lifetime risk regardless of how well-controlled other risk factors are[8]. Because it's genetic, it typically only needs to be tested once in a lifetime, and it isn't part of a standard lipid panel by default.
The honest caveat: as of this guide's writing, there isn't yet a widely approved medication specifically for lowering Lp(a) itself (several are in active clinical trials). Knowing your level still matters, because it reclassifies overall risk and can change how aggressively other, modifiable risk factors — blood pressure, ApoB, smoking — are managed.
Familial Hypercholesterolemia: Common and Commonly Missed
Familial hypercholesterolemia (FH) is a genetic condition causing markedly elevated LDL (low-density lipoprotein) cholesterol from birth, driven by mutations affecting how the body clears LDL from the blood. A European consensus statement estimates the prevalence at roughly 1 in 200 to 1 in 500 people, depending on the population studied — making it one of the most common serious genetic conditions in medicine — yet fewer than 1% of people with it are diagnosed in most countries[9]. Untreated, it's associated with dramatically elevated lifetime cardiovascular risk, with heart disease often striking decades earlier than in the general population.
Visible signs worth knowing: markedly elevated LDL can show up physically as xanthomas (fatty deposits under the skin, often over tendons), xanthelasma (fatty deposits around the eyelids), or corneal arcus (a pale ring around the edge of the iris) — worth recognising given how few people with FH are ever formally diagnosed.
A red flag worth knowing: LDL cholesterol persistently above roughly 190 mg/dL in an adult, especially alongside a family history of early heart disease (before age 55 in men, 65 in women), is worth a specific conversation with a doctor about FH.
It's highly treatable once identified — statins and other lipid-lowering therapies are generally effective, but only if the underlying condition is recognised rather than treated as ordinary, lifestyle-driven high cholesterol.
Section takeaway
Lp(a) and familial hypercholesterolemia are two of the most commonly overlooked cardiovascular risk factors precisely because they don't respond to lifestyle the way most of this guide does — testing for them once is inexpensive and can meaningfully change how the rest of your risk profile should be managed.